| Gene symbol | KLRK1 | Synonyms | CD314, D12S2489E, KLR, NKG2-D, NKG2D | Type of gene | protein-coding |
| Chromosome | 12 | Map location | 12p13.2 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | killer cell lectin like receptor K1 | ||||
| GTO ID | GTC2457 |
| Trial ID | NCT04550663 |
| Disease | Colorectal Cancer | Hepatocellular Carcinoma | Brain Glioma |
| Altered gene | NKG2D |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | KD-025 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors |
| Year | 2020 |
| Country | China |
| Company sponsor | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
| Other ID(s) | 2020-172-01 |
| Cohort 1 | |||||||||
|
|||||||||